Overview
Allos AI has secured $5 million in seed financing to develop its innovative 'glass-box' causal AI platform aimed at reformulating complex generic drugs. This funding addresses the need for lower-risk methods to enhance the delivery and tolerance of established medications over extended use, appealing to developers and manufacturers in the pharmaceutical industry.
Products
Loading...
Recent Deals
Allos AI has secured $5 million in seed financing to develop its innovative 'glass-box' causal AI platform aimed at reformulating complex generic drugs. This funding addresses the need for lower-risk methods to enhance the delivery and tolerance of established medications over extended use, appealing to developers and manufacturers in the pharmaceutical industry.